Literature DB >> 17910008

The use of Gaussian quadrature for estimation in frailty proportional hazards models.

Lei Liu1, Xuelin Huang.   

Abstract

In this paper, we propose a novel Gaussian quadrature estimation method in various frailty proportional hazards models. We approximate the unspecified baseline hazard by a piecewise constant one, resulting in a parametric model that can be fitted conveniently by Gaussian quadrature tools in standard software such as SAS Proc NLMIXED. We first apply our method to simple frailty models for correlated survival data (e.g. recurrent or clustered failure times), then to joint frailty models for correlated failure times with informative dropout or a dependent terminal event such as death. Simulation studies show that our method compares favorably with the well-received penalized partial likelihood method and the Monte Carlo EM (MCEM) method, for both normal and Gamma frailty models. We apply our method to three real data examples: (1) the time to blindness of both eyes in a diabetic retinopathy study, (2) the joint analysis of recurrent opportunistic diseases in the presence of death for HIV-infected patients, and (3) the joint modeling of local, distant tumor recurrences and patients survival in a soft tissue sarcoma study. The proposed method greatly simplifies the implementation of the (joint) frailty models and makes them much more accessible to general statistical practitioners.

Entities:  

Mesh:

Year:  2008        PMID: 17910008     DOI: 10.1002/sim.3077

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  27 in total

1.  Hierarchical likelihood inference on clustered competing risks data.

Authors:  Nicholas J Christian; Il Do Ha; Jong-Hyeon Jeong
Journal:  Stat Med       Date:  2015-08-16       Impact factor: 2.373

2.  Semiparametric analysis of panel count data with correlated observation and follow-up times.

Authors:  Xin He; Xingwei Tong; Jianguo Sun
Journal:  Lifetime Data Anal       Date:  2008-12-10       Impact factor: 1.588

3.  Exploring causality mechanism in the joint analysis of longitudinal and survival data.

Authors:  Lei Liu; Cheng Zheng; Joseph Kang
Journal:  Stat Med       Date:  2018-06-07       Impact factor: 2.373

4.  Characterizing durations of heroin abstinence in the California Civil Addict Program: results from a 33-year observational cohort study.

Authors:  Bohdan Nosyk; M Douglas Anglin; Mary-Lynn Brecht; Viviane Dias Lima; Yih-Ing Hser
Journal:  Am J Epidemiol       Date:  2013-02-27       Impact factor: 4.897

5.  A positive stable frailty model for clustered failure time data with covariate-dependent frailty.

Authors:  Dandan Liu; John D Kalbfleisch; Douglas E Schaubel
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

6.  Sample size determination in shared frailty models for multivariate time-to-event data.

Authors:  Liddy M Chen; Joseph G Ibrahim; Haitao Chu
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

7.  Penalized survival models for the analysis of alternating recurrent event data.

Authors:  Lili Wang; Kevin He; Douglas E Schaubel
Journal:  Biometrics       Date:  2019-11-11       Impact factor: 2.571

8.  Parametric frailty models for clustered data with arbitrary censoring: application to effect of male circumcision on HPV clearance.

Authors:  Xiangrong Kong; Kellie J Archer; Lawrence H Moulton; Ronald H Gray; Mei-Cheng Wang
Journal:  BMC Med Res Methodol       Date:  2010-05-06       Impact factor: 4.615

9.  Evaluation of estimation methods and power of tests of discrete covariates in repeated time-to-event parametric models: application to Gaucher patients treated by imiglucerase.

Authors:  Marie Vigan; Jérôme Stirnemann; France Mentré
Journal:  AAPS J       Date:  2014-02-26       Impact factor: 4.009

10.  Joint covariate-adjusted score test statistics for recurrent events and a terminal event.

Authors:  Rui Song; Jianwen Cai
Journal:  Lifetime Data Anal       Date:  2009-12-01       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.